NCT06983366 Validation and Clinical Utility of the Lung Sliding Index (LSI) for Differentiating Pulmonary Diseases
| NCT ID | NCT06983366 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Assiut University |
| Condition | COPD |
| Study Type | OBSERVATIONAL |
| Enrollment | 700 participants |
| Start Date | 2025-05-30 |
| Primary Completion | 2026-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 700 participants in total. It began in 2025-05-30 with a primary completion date of 2026-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This upcoming case-control study aims to confirm the Lung Sliding Index (LSI), a new ultrasound score that measures how well the pleura moves, in various lung diseases. The study will check how well the LSI can tell apart different lung diseases (like pneumothorax, interstitial lung disease, COPD, pneumonia, and pulmonary edema), how it relates to signs of disease severity, and how consistent the results are between different operators who have received the same training. Secondary objectives include assessing patient and operator satisfaction and feasibility using validated Likert scales.
Eligibility Criteria
Inclusion Criteria: * Age 18 years and older. * Diagnosed with one of the specified pulmonary diseases, or a healthy control * Able to provide written informed consent Exclusion Criteria: * Inability to tolerate or undergo a lung ultrasound * Extensive chest wall pathology precluding assessment * Unscorable \>2 zones per protocol * Withdrawal of consent * Mechanically-ventilated patients
Contact & Investigator
Ahmad M. Shaddad, MD
PRINCIPAL INVESTIGATOR
Assiut University
Frequently Asked Questions
Who can join the NCT06983366 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying COPD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06983366 currently recruiting?
Yes, NCT06983366 is actively recruiting participants. Contact the research team at shaddad_ahmad@yahoo.com for enrollment information.
Where is the NCT06983366 trial being conducted?
This trial is being conducted at Asyut, Egypt.
Who is sponsoring the NCT06983366 clinical trial?
NCT06983366 is sponsored by Assiut University. The principal investigator is Ahmad M. Shaddad, MD at Assiut University. The trial plans to enroll 700 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.